Metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease risk: Dual aetiology or metabolic dysfunction?

被引：1
|
作者：
Ma, Tianyi [1 ]
Yuan, Huawei [1 ]
Guo, Zhanfang [1 ]
机构：
[1] Dalian Univ Technol, Cent Hosp, Dept Gastroenterol & Hepatol, Dalian, Peoples R China
来源：
LIVER INTERNATIONAL | 2024年 / 44卷 / 11期
关键词：
D O I：
10.1111/liv.16082
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：3103 / 3104
页数：2
相关论文
共 50 条
  • [1] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease
    Chang, Hui-Chin
    Gau, Shuo-Yan
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E14 - E14
  • [2] Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Higuchi, Mayu
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2021, 51 (11) : 1172 - 1173
  • [3] Associations between metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease
    Wen, Wen
    Fan, Hua
    Zhang, Shenghui
    Hu, Siqi
    Chen, Chen
    Tang, Jiake
    You, Yao
    Wang, Chunyi
    Li, Jie
    Luo, Lin
    Cheng, Yongran
    Zhou, Mengyun
    Zhao, Xuezhi
    Tan, Tao
    Xu, Fangfang
    Fu, Xinyan
    Chen, Juan
    Dong, Peng
    Zhang, Xingwei
    Wang, Mingwei
    Feng, Yan
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 368 (06): : 557 - 568
  • [4] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease Reply
    Yeoh, Aaron
    Cheung, Ramsey
    Ahmed, Aijaz
    Chitnis, Amit S.
    Do, Albert
    Wong, Robert J.
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E15 - E15
  • [5] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Min Kyu Kang
    Yu Rim Lee
    Se Young Jang
    Won Young Tak
    Young Oh Kweon
    Jeong Eun Song
    Rohit Loomba
    Soo Young Park
    Jung Gil Park
    Hepatology International, 2023, 17 : 626 - 635
  • [6] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Xiao-Dong Zhou
    Jingjing Cai
    Giovanni Targher
    Christopher D. Byrne
    Michael D. Shapiro
    Ki-Chul Sung
    Virend K. Somers
    C. Anwar A. Chahal
    Jacob George
    Li-Li Chen
    Yong Zhou
    Ming-Hua Zheng
    Cardiovascular Diabetology, 21
  • [7] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Kang, Min Kyu
    Lee, Yu Rim
    Jang, Se Young
    Tak, Won Young
    Kweon, Young Oh
    Song, Jeong Eun
    Loomba, Rohit
    Park, Soo Young
    Park, Jung Gil
    HEPATOLOGY INTERNATIONAL, 2023, 17 (03) : 626 - 635
  • [8] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Zhou, Xiao-Dong
    Cai, Jingjing
    Targher, Giovanni
    Byrne, Christopher D.
    Shapiro, Michael D.
    Sung, Ki-Chul
    Somers, Virend K.
    Chahal, C. Anwar A.
    George, Jacob
    Chen, Li-Li
    Zhou, Yong
    Zheng, Ming-Hua
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [9] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [10] Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
    Lee, Hyeok-Hee
    Lee, Han Ah
    Kim, Eun-Jin
    Kim, Hwi Young
    Kim, Hyeon Chang
    Ahn, Sang Hoon
    Lee, Hokyou
    Kim, Seung Up
    GUT, 2024, 73 (03) : 533 - 540
12345